Development of Leprosy in a Patient with Rheumatoid Arthritis During Treatment with Etanercept: A Case Report

Seminars in Arthritis and Rheumatism, 05/03/2012

This is the first case of leprosy due to anti–tumor necrosis factor (TNF) therapy reported in Europe. Clinicians should be aware of this and other types of atypical and serious infections that patients may suffer from when treated with anti–TNF agents.

Print Article Summary Cat 2 CME Report